Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01335399
Brief Title: Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma (ELOQUENT - 1)

First Submitted : April 13, 2011
First Submitted that Met QC Criteria : April 13, 2011
First Posted : April 14, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : October 31, 2018
Last Update Posted : November 1, 2018